Skip to main content
. 2014 Mar 19;3(3):667–673. doi: 10.1002/cam4.225

Table 2.

IFD by prophylaxis group

IFD Number of patients (%) P-value

Fluconazole group (n = 65) Posaconazole group (n = 65)
Patients with proven/probable IFDs 7 (10.8) 0 (0) 0.013
Proven/Probable IFDs Pathogen
 Mold 1 (1.5)
  Aspergillus 1 (1.5)
  Fusariosis 1 (1.5)
  Zygomycosis 1 (1.5)
 Yeast 1 (1.5)
  Candida albicans 1 (1.5)
  C. glabrata 1 (1.5)
  C.guilliermondii
  C. krusei
Patients with possible IFDs 10 (15.4) 6 (9.2) 0.29
Total patients with IFDs 17 (27.0) 6 (9.2) 0.012

IFD, Invasive fungal disease.